Fresenius Kabi
Chris Lobo is an accomplished professional with extensive experience in data analytics and business intelligence. Currently serving as the Global Head of Data and Analytics at Fresenius Kabi since November 2020, Chris specializes in GenAI, Machine Learning, and Master Data Management, utilizing tools such as SAP BW, PowerBI, Qlik, and Tableau. Prior to this role, Chris was the Director of Analytics and Reporting at Daiichi Sankyo Europe GmbH, where responsibilities included strategy and implementation of analytics, forecasting, and team management. Chris also held multiple positions at W. L. Gore & Associates, culminating in the role of Enterprise Business Intelligence Champion, and has experience at Oracle as a Quality Assurance Engineer and Wipro Limited as a Project Engineer. Chris holds an MBA in International Business from the Technical University of Freiberg and Wuhan University of Science and Technology, along with a Bachelor of Engineering in Electronics and Communication from Adichunchunagiri Institute of Technology.
This person is not in the org chart
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.